POZEN Inc. (POZN) Receives Decision from AstraZeneca (AZN) to File PN 400 NDA
Tweet Send to a Friend
POZEN Inc. (NASDAQ: POZN) reported that AstraZeneca (NYSE: AZN) has made the decision to have POZEN file the New Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


